Hantavirus pulmonary syndrome

The first 100 US cases

Ali S Khan, Rima F. Khabbaz, Lori R. Armstrong, Robert C. Holman, Sally P. Bauer, Judith Graber, Tara Strine, Gayle Miller, Susan Reef, Jordan Tappero, Pierre E. Rollin, Stuart T. Nichol, Sherif R. Zaki, Ralph T. Bryan, Louisa E. Chapman, C. J. Peters, Thomas G. Ksiazek

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

In the spring of 1993, hantavirus pulmonary syndrome (HPS) 'emerged' in the southwestern United States, where a multiagency investigation led to the rapid description of this new clinical entity and its etiology. Analysis of the first 100 US cases identified showed that the disease was distributed in 21 states, had gone unrecognized since at least 1959, and had a distinct spring-early summer seasonality. Of the infected persons, 54% were male; 63% were Caucasian, 35% were Native American, and 2% were African American. The average age of case-patients was 34.9 years, and 8 were children or adolescents aged ≤ 16 years. The overall case-fatality rate was 52%. There was a 91% concordance among serologic, immunohistochemical, and molecular results. HPS in the United States is caused by at least three newly described pathogenic hantaviruses, each of which has a distinct rodent host, and cases of HPS have been recently recognized in Canada and South America. National surveillance of this sporadic disease remains essential for further defining the epidemiology and clinical spectrum.

Original languageEnglish (US)
Pages (from-to)1297-1303
Number of pages7
JournalJournal of Infectious Diseases
Volume173
Issue number6
DOIs
StatePublished - Jan 1 1996

Fingerprint

Hantavirus Pulmonary Syndrome
Southwestern United States
Hantavirus
North American Indians
South America
African Americans
Canada
Rodentia
Epidemiology
Mortality

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Khan, A. S., Khabbaz, R. F., Armstrong, L. R., Holman, R. C., Bauer, S. P., Graber, J., ... Ksiazek, T. G. (1996). Hantavirus pulmonary syndrome: The first 100 US cases. Journal of Infectious Diseases, 173(6), 1297-1303. https://doi.org/10.1093/infdis/173.6.1297

Hantavirus pulmonary syndrome : The first 100 US cases. / Khan, Ali S; Khabbaz, Rima F.; Armstrong, Lori R.; Holman, Robert C.; Bauer, Sally P.; Graber, Judith; Strine, Tara; Miller, Gayle; Reef, Susan; Tappero, Jordan; Rollin, Pierre E.; Nichol, Stuart T.; Zaki, Sherif R.; Bryan, Ralph T.; Chapman, Louisa E.; Peters, C. J.; Ksiazek, Thomas G.

In: Journal of Infectious Diseases, Vol. 173, No. 6, 01.01.1996, p. 1297-1303.

Research output: Contribution to journalArticle

Khan, AS, Khabbaz, RF, Armstrong, LR, Holman, RC, Bauer, SP, Graber, J, Strine, T, Miller, G, Reef, S, Tappero, J, Rollin, PE, Nichol, ST, Zaki, SR, Bryan, RT, Chapman, LE, Peters, CJ & Ksiazek, TG 1996, 'Hantavirus pulmonary syndrome: The first 100 US cases', Journal of Infectious Diseases, vol. 173, no. 6, pp. 1297-1303. https://doi.org/10.1093/infdis/173.6.1297
Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J et al. Hantavirus pulmonary syndrome: The first 100 US cases. Journal of Infectious Diseases. 1996 Jan 1;173(6):1297-1303. https://doi.org/10.1093/infdis/173.6.1297
Khan, Ali S ; Khabbaz, Rima F. ; Armstrong, Lori R. ; Holman, Robert C. ; Bauer, Sally P. ; Graber, Judith ; Strine, Tara ; Miller, Gayle ; Reef, Susan ; Tappero, Jordan ; Rollin, Pierre E. ; Nichol, Stuart T. ; Zaki, Sherif R. ; Bryan, Ralph T. ; Chapman, Louisa E. ; Peters, C. J. ; Ksiazek, Thomas G. / Hantavirus pulmonary syndrome : The first 100 US cases. In: Journal of Infectious Diseases. 1996 ; Vol. 173, No. 6. pp. 1297-1303.
@article{ce62c0adb78d4a59a7c51c4450ed8c0d,
title = "Hantavirus pulmonary syndrome: The first 100 US cases",
abstract = "In the spring of 1993, hantavirus pulmonary syndrome (HPS) 'emerged' in the southwestern United States, where a multiagency investigation led to the rapid description of this new clinical entity and its etiology. Analysis of the first 100 US cases identified showed that the disease was distributed in 21 states, had gone unrecognized since at least 1959, and had a distinct spring-early summer seasonality. Of the infected persons, 54{\%} were male; 63{\%} were Caucasian, 35{\%} were Native American, and 2{\%} were African American. The average age of case-patients was 34.9 years, and 8 were children or adolescents aged ≤ 16 years. The overall case-fatality rate was 52{\%}. There was a 91{\%} concordance among serologic, immunohistochemical, and molecular results. HPS in the United States is caused by at least three newly described pathogenic hantaviruses, each of which has a distinct rodent host, and cases of HPS have been recently recognized in Canada and South America. National surveillance of this sporadic disease remains essential for further defining the epidemiology and clinical spectrum.",
author = "Khan, {Ali S} and Khabbaz, {Rima F.} and Armstrong, {Lori R.} and Holman, {Robert C.} and Bauer, {Sally P.} and Judith Graber and Tara Strine and Gayle Miller and Susan Reef and Jordan Tappero and Rollin, {Pierre E.} and Nichol, {Stuart T.} and Zaki, {Sherif R.} and Bryan, {Ralph T.} and Chapman, {Louisa E.} and Peters, {C. J.} and Ksiazek, {Thomas G.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1093/infdis/173.6.1297",
language = "English (US)",
volume = "173",
pages = "1297--1303",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Hantavirus pulmonary syndrome

T2 - The first 100 US cases

AU - Khan, Ali S

AU - Khabbaz, Rima F.

AU - Armstrong, Lori R.

AU - Holman, Robert C.

AU - Bauer, Sally P.

AU - Graber, Judith

AU - Strine, Tara

AU - Miller, Gayle

AU - Reef, Susan

AU - Tappero, Jordan

AU - Rollin, Pierre E.

AU - Nichol, Stuart T.

AU - Zaki, Sherif R.

AU - Bryan, Ralph T.

AU - Chapman, Louisa E.

AU - Peters, C. J.

AU - Ksiazek, Thomas G.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - In the spring of 1993, hantavirus pulmonary syndrome (HPS) 'emerged' in the southwestern United States, where a multiagency investigation led to the rapid description of this new clinical entity and its etiology. Analysis of the first 100 US cases identified showed that the disease was distributed in 21 states, had gone unrecognized since at least 1959, and had a distinct spring-early summer seasonality. Of the infected persons, 54% were male; 63% were Caucasian, 35% were Native American, and 2% were African American. The average age of case-patients was 34.9 years, and 8 were children or adolescents aged ≤ 16 years. The overall case-fatality rate was 52%. There was a 91% concordance among serologic, immunohistochemical, and molecular results. HPS in the United States is caused by at least three newly described pathogenic hantaviruses, each of which has a distinct rodent host, and cases of HPS have been recently recognized in Canada and South America. National surveillance of this sporadic disease remains essential for further defining the epidemiology and clinical spectrum.

AB - In the spring of 1993, hantavirus pulmonary syndrome (HPS) 'emerged' in the southwestern United States, where a multiagency investigation led to the rapid description of this new clinical entity and its etiology. Analysis of the first 100 US cases identified showed that the disease was distributed in 21 states, had gone unrecognized since at least 1959, and had a distinct spring-early summer seasonality. Of the infected persons, 54% were male; 63% were Caucasian, 35% were Native American, and 2% were African American. The average age of case-patients was 34.9 years, and 8 were children or adolescents aged ≤ 16 years. The overall case-fatality rate was 52%. There was a 91% concordance among serologic, immunohistochemical, and molecular results. HPS in the United States is caused by at least three newly described pathogenic hantaviruses, each of which has a distinct rodent host, and cases of HPS have been recently recognized in Canada and South America. National surveillance of this sporadic disease remains essential for further defining the epidemiology and clinical spectrum.

UR - http://www.scopus.com/inward/record.url?scp=19244362513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19244362513&partnerID=8YFLogxK

U2 - 10.1093/infdis/173.6.1297

DO - 10.1093/infdis/173.6.1297

M3 - Article

VL - 173

SP - 1297

EP - 1303

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -